Skip to main content
OpenTrials

Clinical trial condition

Lysosomal Storage Diseases, Nervous System

Explore clinical trials studying Lysosomal Storage Diseases, Nervous System. Study availability and eligibility vary by location and protocol.

513 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lysosomal Storage Diseases, Nervous System trial results

Completed

Auto-antibodies Prevalence and CD1 Role in Gaucher Disease

NCT02650219

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Internal Medicine Department, Hôpital Minjoz, Besançon, France
  • Intensive Care Department, Hôpital Pellegrin, Bordeaux, France
  • Internal Medicine Department, Hôpital Beaujon, Clichy, France
  • Internal Medicine and Clinical Immunology Department, CHU, Dijon, France
View Trial Details
Completed

A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease

NCT00140621

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Fujita Health University Hospital Aichi, Japan
  • Sapporo Medical University Hospital Hokkaido, Japan
  • Akune Citizen Hospital Kagoshima, Japan
  • Tohoku University Hospital Miyagi, Japan
View Trial Details
Completed

A Prospective, Observational Study in Patients With Late-Onset Pompe Disease

NCT00077662

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • Children's Hospital Medical Center Washington D.C., District of Columbia, United States
  • School of Medicine, Campus Box 8111 St Louis, Missouri, United States
  • Children's Hospital & Regional Medical Center Seattle, Washington, United States
  • Institut de Myologie, Groupe Hospitalier Pitie-Salpetriere, Batimant Babinski Paris, France
View Trial Details
Completed

Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease

NCT00113035

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Tower Hematology/Oncology Medical Group Beverly Hills, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Washington University Medical Center St Louis, Missouri, United States
  • Mount Sinai School of Medicine New York, United States
View Trial Details
Completed

A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease

NCT00158600

Conditions
Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Washington University Medical Center St Louis, Missouri, United States
  • Mount Sinai School of Medicine New York, United States
View Trial Details

Related conditions